23
Views
0
CrossRef citations to date
0
Altmetric
Miscellaneous

Novel lentiviral vectors for human gene therapy

Pages 997-1001 | Published online: 23 Feb 2005

Bibliography

  • ANDERSON WF: Human gene therapy. Nature (1998) 392\(Suppl. 6679):25–30.
  • RUSSELL SJ: Science, medicine, and the future: gene therapy. Brit. Med. J. (1997) 3 15 (7118):1289–1292.
  • VERMA IM SOMIA N: Gene therapy - promises, prob-lems and prospects. Nature (1997) 389(6648):239–242.
  • ROBBINS PD, TAHARA H, GHIVIZZANI SC: Viral vectors for gene therapy. Trends Biotechnol (1998) 16(1)35–40.
  • SMITH AE: Viral vectors in gene therapy. Ann. Rev. Mi-crobial (1995) 49:807–838.
  • PANTALEO G, FAUCI AS: Immunopathogenesis of HIV infection. Ann. Rev. Microbial (1996)50:825–54.
  • COHEN 0J, KINTER A, FAUCI AS: Host factors in thepathogenesis of HIV disease. Immunol. Rev. (1997) 159:31–48.
  • HO DD, NEUMANN AU, PERELSON AS et al.: Rapid turn-over of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (1995) 3 73 (6510):123–126.
  • PERELSON AS, NEUMANN AU, MARKOWITZ M, LEONARDJM, HO DD: HIV-1 dynamics in viva virion clearance rate, infected cell lifespan, and viral generation time. Science (1996) 271(5255):1582–1586.
  • PERELSON AS, ESSUNGER P, CAO Y et al.: Decay charac-teristics of HIV-1-infected compartments during com-bination therapy. Nature (1997) 387(6629)188–191.
  • FINZI D, HERMANKOVA M, PIERSON T et al Identifica- tion of a reservoir for HIV-1 in patients on highly ac-tive antiretroviral therapy. Science (1 9 9 7) 278(5341)1295–1300.
  • DUNBAR CE: Gene transfer to hematopoietic stem cells: implications for gene therapy of human disease. Ann. Rev. Med (1996) 47:11–20.
  • GALLAY P, STITT V, MUNDY C, OETTINGER M, TRONO D: Role of the karyopherin pathway in human immuno-deficiency virus type 1 nuclear import. J. Virol (1996) 70 (2) :1027–1032.
  • GALLAY P, HOPE T, CHIN D, TRONO D: 11IV-1 infection of nondividing cells through the recognition of inte-grase by the importin/karyopherin pathway. Proc. Natl. Acad. ScL USA. (1997) 94(18):9825–30
  • KAFRI T, BLOMER U, PETERSON DA, GAGE FH, VERMA IM: Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. (1997) 17(3):314–317.
  • BLOMER U, NALDINI L, KAFRI T et al.: Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. (1997) 71 (9) :6641–6649.
  • MIYOSHI H, TAKAHASHI M, GAGE FH, VERMA IM: Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. ScL USA (1997) 94(19):10319–10323.
  • REISER J, HARMISON G, KLUEPFEL-STAHL S et al.: Trans-duction of nondividing cells using pseudotyped defec-tive high-titer HIV type 1 particles. Proc. Natl Acad. ScL USA (1996) 93(26):15266–15271.
  • POESCHLA E, WONG-STAAL F, LOONEY DJ: Efficient transduction of non-dividing human cells by feline im-munodeficiency virus lentiviral vectors. Nature Med. (1998) 4(3):354–357.
  • KARR BM, CHEBLOUNE Y, LEUNG K, NARAYAN 0: Ge-netic characterization of two phenotypically distinct North American ovine lentiviruses and their possible origin from caprine arthritis-encephalitis virus. Virol-ogy 1996 225(0:1–10.
  • MICHAELS MG: Infectious concerns of cross-species transplantation: xenozoonoses. World J. Surg. (1997) 21(9)968–974.
  • NALDINI L, BLOMER U, GALLAY P et al.: In vivo gene de-livery and stable transduction of nondividing cells by a lentiviral vector. Science (1996) 272(5259):263–267.
  • NALDINI L, BLOMER U, GAGE FH, TRONO D, VERMA IM: Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains in-jected with a lentiviral vector. Proc. Natl. Acad. ScL USA (1996) 93(20:11382–11388.
  • ZUFFEREY R, NAGY D, MANDEL RJ, NALDINI L, TRONO D: Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. (1997) i5(9):871–875.
  • WYAND MS, MANSON KH, GARCIA-MOLL M, MONTEFI-ORI D, DESROSIERS RC: Vaccine protection by a triple deletion mutant of simian immunodeficiency virus. J. Virol. (1996) 70(6):3724–3733.
  • WYAND MS, MANSON KH, LACKNER AA, DESROSIERS RC: Resistance of neonatal monkeys to live attenuated vac-cine strains of simian immunodeficiency virus. Nature Med. (1997) 3(0:32–36.
  • REIPRICH S, GUNDLACH BR, FLECKENSTEIN B, UBERLA K: Replication-competent chimeric lenti-oncovirus with expanded host cell tropism. J. Vim]. (1997) 71 (4):3328–3331.
  • DROPULIC B, JEANG KT: Gene therapy for human im-munodeficiency virus infection: genetic antiviral strategies and targets for intervention. Human Gene Ther. (1994) 5(8):927–939.,
  • DROPULIC B, HERMANKOVA M, PITHA PM: A condition-ally replicating 11IV-1 vector interferes with wild-type 11IV-1 replication and spread. Proc. Natl. Acad. Sci. USA (1996) 93(2011103–11108.
  • MOSIER DE: Human immunodeficiency virus infection of human cells transplanted to severe combined im-munodeficient mice. Adv. Immunol (1996) 63:79–125.
  • ROSENZWEIG M, MARKS DF, HEMPEL D et al.: Intracellu-lar immunization of rhesus CD34+ hematopoietic pro-genitor cells with a hairpin ribozyme protects T-cells and macrophages from simian immunodeficiency vi-rus infection. Blood (1997) 90(12):4822–4831.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.